Chi Sheng Chemical (4111) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Chi Sheng Chemical (4111) has a cash flow conversion efficiency ratio of 0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$17.35 Million ≈ $546.49K USD) by net assets (NT$1.29 Billion ≈ $40.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 4111 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Chi Sheng Chemical - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Chi Sheng Chemical's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Chi Sheng Chemical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chi Sheng Chemical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Barksdale Resources Corp
V:BRO
|
-0.017x |
|
Ilji Technology Co. Ltd
KQ:019540
|
-0.014x |
|
Chia Her Industrial Co Ltd
TW:1449
|
-0.040x |
|
Zee Media Corporation Limited
NSE:ZEEMEDIA
|
0.290x |
|
Saga Communications Inc
NASDAQ:SGA
|
-0.008x |
|
Chung Fu Tex-International Corp
TW:1435
|
-0.010x |
|
Atari S.A.
PA:ALATA
|
-0.412x |
|
General Commercial & Industrial S.A
AT:GEBKA
|
0.044x |
Annual Cash Flow Conversion Efficiency for Chi Sheng Chemical (2017–2024)
The table below shows the annual cash flow conversion efficiency of Chi Sheng Chemical from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Chi Sheng Chemical.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.27 Billion ≈ $40.16 Million |
NT$213.20 Million ≈ $6.72 Million |
0.167x | +173.64% |
| 2023-12-31 | NT$1.22 Billion ≈ $38.41 Million |
NT$74.52 Million ≈ $2.35 Million |
0.061x | -65.23% |
| 2022-12-31 | NT$1.22 Billion ≈ $38.50 Million |
NT$214.86 Million ≈ $6.77 Million |
0.176x | +38.89% |
| 2021-12-31 | NT$1.10 Billion ≈ $34.68 Million |
NT$139.33 Million ≈ $4.39 Million |
0.127x | -5.13% |
| 2020-12-31 | NT$1.08 Billion ≈ $33.89 Million |
NT$143.53 Million ≈ $4.52 Million |
0.133x | -12.25% |
| 2019-12-31 | NT$1.07 Billion ≈ $33.77 Million |
NT$162.96 Million ≈ $5.13 Million |
0.152x | +39.15% |
| 2018-12-31 | NT$1.05 Billion ≈ $32.93 Million |
NT$114.19 Million ≈ $3.60 Million |
0.109x | -36.45% |
| 2017-12-31 | NT$1.05 Billion ≈ $33.19 Million |
NT$181.14 Million ≈ $5.71 Million |
0.172x | -- |
About Chi Sheng Chemical
Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic … Read more